Perepu, Chambers lead trial of proper dosage for COVID-19 thrombosis

Thrombosis is commonly associated with COVID-19; however, the impact of enoxaparin, an anti-clotting drug, on COVID-19 remains uncertain.  Usha Perepu, MBBS, MRCP, clinical associate professor in Hematology, Oncology, and Blood and Marrow Transplantation, and Isaac Chambers, MD, former Hematology and Medical Oncology chief fellow, conducted a multi-center, open-label, randomized, controlled trial comparing the outcome of […]